MedPath

Evaluation of the clinical acceptance of soft contact lenses for shortsightedness in adolescents

Not Applicable
Completed
Conditions
Myopia
Eye Diseases
Registration Number
ISRCTN10586055
Lead Sponsor
CooperVision (United States)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Age 10 to 16 years
2. Spectacle refraction: -0.75 to -6.00D spherical equivalent, maximum anisometropia 1.25D, cylinder up to -1.00DC
3. Best corrected visual acuity of at least 20/25 in each eye
4. Parents/guardians and participant have read and understood the Participant Information Sheet
5. Parents/guardians and participant have read, signed and dated the Informed Consent
6. Have normal eyes with the exception of the need for visual correction
7. Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule

Exclusion Criteria

1. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear
2. Newly prescribed use of some systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator
3. Monocular participants (only one eye with functional vision) or participants fit with only one lens
4. Subjects with slit-lamp findings greater than grade 1 (e.g. edema, infiltrates, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival, anterior segment inflammation) as per ISO 11980, any previous history or signs of a contact lens related corneal inflammatory event (past corneal ulcers), or any other ocular abnormality that may contraindicate contact lens wear at the enrolment visit
5. History of herpetic keratitis, ocular surgery or irregular cornea
6. Enrolment of the family members of the investigator, family members of the investigator’s staff, or individuals living in the households of
these individuals

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath